title: Use of Antipsychotics Pre- and Post-Dissemination of CATIE Data.
abstract: We investigated the share of branded and generic antipsychotics before and after the publication of the CATIE results in September, 2005. According to our data, the publication of the CATIE results has had very little impact on new patient starts. To determine the impact of CATIE on use of olanzapine (Zyprexa((R))) subsequent to first line therapy, we also examined product share for switch/add patients. We found that since the publication of the CATIE results, the use of olanzapine has stabilized, following a decline subsequent to first line therapy, and may potentially be growing very slowly. An expert commentary is provided on the data.
authors.affiliation: Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia.
authors.forename: Elisa F
authors.initials: EF
authors.lastname: Cascade
authors.forename: Amir H
authors.initials: AH
authors.lastname: Kalali
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Lieberman
authors.forename: John
authors.initials: J
authors.lastname: Hsiao
authors.forename: Richard
authors.initials: R
authors.lastname: Keefe
authors.forename: Scott
authors.initials: S
authors.lastname: Stroup